[Raynaud's phenomenon]
- PMID: 19268319
- DOI: 10.1016/j.medcli.2008.11.017
[Raynaud's phenomenon]
Abstract
Raynaud's phenomenon is a frequent reason for seeking of medical attention, since it affects 3-5% of the population. It is characterized by sudden, transient and recurrent episodes of pallor and/or digital cyanosis, after exposure to cold or stressful situations. No known underlying illness is identified in over 80% of cases and consequently these cases are classified as primary Raynaud's phenomenon. Connective tissue diseases, particularly systemic sclerosis, are the main causes of the phenomenon. Once a complete clinical and physical evaluation rule out other causes, a nailfold capillaroscopy and antinuclear antibodies determination are the most useful adjunctive tests. Mild Raynaud's phenomenon can be managed almost exclusively with conservative non-pharmacological lifestyle modifications. However, if a patient develops a severe vascular condition a suitable vasodilator treatment is needed. When critical digital ischemia develops, intravenous treatment with prostaglandin analogues and surgery may be useful.
Comment in
-
[On Raynaud's phenomenon].Med Clin (Barc). 2010 Apr 10;134(10):470; author reply 470-1. doi: 10.1016/j.medcli.2009.06.067. Epub 2009 Dec 21. Med Clin (Barc). 2010. PMID: 20022066 Spanish. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical

